APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aciclovir Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Aciclovir Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025192 pages

Choose your research edition.

Industry ResearchAciclovir Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Aciclovir Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Aciclovir Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aciclovir Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Aciclovir Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Aciclovir Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Aciclovir Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Aciclovir Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aciclovir Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Aciclovir Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Aciclovir Drug include Yiling Pharmaceutical, SHANGHAI CP GENERAL PHARMACEUTICAL, UNITED LABORATOR IES, Kangzheng Pharmaceutical, Fresenius Kabi, Zydus Pharmaceuticals, Vectans Pharma, Talent Healthcare and RelonChem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Aciclovir Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Aciclovir Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Aciclovir Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Aciclovir Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Aciclovir Drug Segment by Company

Yiling Pharmaceutical

SHANGHAI CP GENERAL PHARMACEUTICAL

UNITED LABORATOR IES

Kangzheng Pharmaceutical

Fresenius Kabi

Zydus Pharmaceuticals

Vectans Pharma

Talent Healthcare

RelonChem

Novus Life Sciences

Cipla

Blue Pharma

Actiza Pharma

Aciclovir Drug Segment by Type

Topical Ointment

Oral Tablet

Lntravenous Dosage Forms

Aciclovir Drug Segment by Application

Shingles

Herpes Simplex Virus Infection

Chickenpox in Immunocompromised Persons

Others

Aciclovir Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aciclovir Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aciclovir Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aciclovir Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Aciclovir Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Aciclovir Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Aciclovir Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Aciclovir Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Aciclovir Drug Industry Trends Table 2. Aciclovir Drug Industry Drivers Table 3. Aciclovir Drug Industry Opportunities and Challenges Table 4. Aciclovir Drug Industry Restraints Table 5. Global Aciclovir Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Aciclovir Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Aciclovir Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Aciclovir Drug Sales Market Share by Manufacturers Table 9. Global Aciclovir Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Aciclovir Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Aciclovir Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Aciclovir Drug Manufacturers, Product Type & Application Table 13. Global Aciclovir Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Aciclovir Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Topical Ointment Table 17. Major Manufacturers of Oral Tablet Table 18. Major Manufacturers of Lntravenous Dosage Forms Table 19. Global Aciclovir Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Aciclovir Drug Sales by Type (2021-2026) & (K Units) Table 21. Global Aciclovir Drug Sales by Type (2027-2032) & (K Units) Table 22. Global Aciclovir Drug Sales Market Share by Type (2021-2026) Table 23. Global Aciclovir Drug Sales Market Share by Type (2027-2032) Table 24. Global Aciclovir Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Aciclovir Drug Revenue by Type (2021-2026) & (K Units) Table 26. Global Aciclovir Drug Revenue by Type (2027-2032) & (K Units) Table 27. Global Aciclovir Drug Revenue Market Share by Type (2021-2026) Table 28. Global Aciclovir Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Shingles Table 30. Major Manufacturers of Herpes Simplex Virus Infection Table 31. Major Manufacturers of Chickenpox in Immunocompromised Persons Table 32. Major Manufacturers of Others Table 33. Global Aciclovir Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Aciclovir Drug Sales by Application (2021-2026) & (K Units) Table 35. Global Aciclovir Drug Sales by Application (2027-2032) & (K Units) Table 36. Global Aciclovir Drug Sales Market Share by Application (2021-2026) Table 37. Global Aciclovir Drug Sales Market Share by Application (2027-2032) Table 38. Global Aciclovir Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Aciclovir Drug Revenue by Application (2021-2026) & (K Units) Table 40. Global Aciclovir Drug Revenue by Application (2027-2032) & (K Units) Table 41. Global Aciclovir Drug Revenue Market Share by Application (2021-2026) Table 42. Global Aciclovir Drug Revenue Market Share by Application (2027-2032) Table 43. Global Aciclovir Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Aciclovir Drug Sales by Region (2021-2026) & (K Units) Table 45. Global Aciclovir Drug Sales Market Share by Region (2021-2026) Table 46. Global Aciclovir Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Aciclovir Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Aciclovir Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Aciclovir Drug Sales by Country (2021-2026) & (K Units) Table 50. North America Aciclovir Drug Sales by Country (2027-2032) & (K Units) Table 51. Europe Aciclovir Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Aciclovir Drug Sales by Country (2021-2026) & (K Units) Table 53. Europe Aciclovir Drug Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Aciclovir Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Aciclovir Drug Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Aciclovir Drug Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Aciclovir Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Aciclovir Drug Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Aciclovir Drug Sales by Country (2027-2032) & (K Units) Table 60. Global Aciclovir Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Aciclovir Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Aciclovir Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Aciclovir Drug Revenue Market Share by Region (2021-2026) Table 64. Global Aciclovir Drug Revenue Market Share by Region (2027-2032) Table 65. Yiling Pharmaceutical Company Information Table 66. Yiling Pharmaceutical Business Overview Table 67. Yiling Pharmaceutical Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Yiling Pharmaceutical Aciclovir Drug Product Portfolio Table 69. Yiling Pharmaceutical Recent Development Table 70. SHANGHAI CP GENERAL PHARMACEUTICAL Company Information Table 71. SHANGHAI CP GENERAL PHARMACEUTICAL Business Overview Table 72. SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Product Portfolio Table 74. SHANGHAI CP GENERAL PHARMACEUTICAL Recent Development Table 75. UNITED LABORATOR IES Company Information Table 76. UNITED LABORATOR IES Business Overview Table 77. UNITED LABORATOR IES Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. UNITED LABORATOR IES Aciclovir Drug Product Portfolio Table 79. UNITED LABORATOR IES Recent Development Table 80. Kangzheng Pharmaceutical Company Information Table 81. Kangzheng Pharmaceutical Business Overview Table 82. Kangzheng Pharmaceutical Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Kangzheng Pharmaceutical Aciclovir Drug Product Portfolio Table 84. Kangzheng Pharmaceutical Recent Development Table 85. Fresenius Kabi Company Information Table 86. Fresenius Kabi Business Overview Table 87. Fresenius Kabi Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Fresenius Kabi Aciclovir Drug Product Portfolio Table 89. Fresenius Kabi Recent Development Table 90. Zydus Pharmaceuticals Company Information Table 91. Zydus Pharmaceuticals Business Overview Table 92. Zydus Pharmaceuticals Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Zydus Pharmaceuticals Aciclovir Drug Product Portfolio Table 94. Zydus Pharmaceuticals Recent Development Table 95. Vectans Pharma Company Information Table 96. Vectans Pharma Business Overview Table 97. Vectans Pharma Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Vectans Pharma Aciclovir Drug Product Portfolio Table 99. Vectans Pharma Recent Development Table 100. Talent Healthcare Company Information Table 101. Talent Healthcare Business Overview Table 102. Talent Healthcare Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Talent Healthcare Aciclovir Drug Product Portfolio Table 104. Talent Healthcare Recent Development Table 105. RelonChem Company Information Table 106. RelonChem Business Overview Table 107. RelonChem Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. RelonChem Aciclovir Drug Product Portfolio Table 109. RelonChem Recent Development Table 110. Novus Life Sciences Company Information Table 111. Novus Life Sciences Business Overview Table 112. Novus Life Sciences Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Novus Life Sciences Aciclovir Drug Product Portfolio Table 114. Novus Life Sciences Recent Development Table 115. Cipla Company Information Table 116. Cipla Business Overview Table 117. Cipla Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Cipla Aciclovir Drug Product Portfolio Table 119. Cipla Recent Development Table 120. Blue Pharma Company Information Table 121. Blue Pharma Business Overview Table 122. Blue Pharma Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Blue Pharma Aciclovir Drug Product Portfolio Table 124. Blue Pharma Recent Development Table 125. Actiza Pharma Company Information Table 126. Actiza Pharma Business Overview Table 127. Actiza Pharma Aciclovir Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Actiza Pharma Aciclovir Drug Product Portfolio Table 129. Actiza Pharma Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Aciclovir Drug Distributors List Table 133. Aciclovir Drug Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Aciclovir Drug Product Image Figure 2. Global Aciclovir Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aciclovir Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Aciclovir Drug Sales (2021-2032) & (K Units) Figure 5. Global Aciclovir Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Aciclovir Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Topical Ointment Image Figure 9. Oral Tablet Image Figure 10. Lntravenous Dosage Forms Image Figure 11. Global Aciclovir Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Aciclovir Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Aciclovir Drug Sales Market Share by Type (2021-2032) Figure 14. Global Aciclovir Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Aciclovir Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Aciclovir Drug Revenue Market Share by Type (2021-2032) Figure 17. Shingles Image Figure 18. Herpes Simplex Virus Infection Image Figure 19. Chickenpox in Immunocompromised Persons Image Figure 20. Others Image Figure 21. Global Aciclovir Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Aciclovir Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Aciclovir Drug Sales Market Share by Application (2021-2032) Figure 24. Global Aciclovir Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Aciclovir Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Aciclovir Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Aciclovir Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Aciclovir Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Aciclovir Drug Sales Market Share by Country (2021-2032) Figure 41. China Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Aciclovir Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Aciclovir Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Aciclovir Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Aciclovir Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Aciclovir Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Aciclovir Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Aciclovir Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Aciclovir Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Aciclovir Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Aciclovir Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Aciclovir Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Aciclovir Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Aciclovir Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Aciclovir Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Topical Ointment
  • Oral Tablet
  • Lntravenous Dosage Forms
Applications
  • Shingles
  • Herpes Simplex Virus Infection
  • Chickenpox in Immunocompromised Persons
  • Others
Companies covered
  • Yiling Pharmaceutical
  • SHANGHAI CP GENERAL PHARMACEUTICAL
  • UNITED LABORATOR IES
  • Kangzheng Pharmaceutical
  • Fresenius Kabi
  • Zydus Pharmaceuticals
  • Vectans Pharma
  • Talent Healthcare
  • RelonChem
  • Novus Life Sciences
  • Cipla
  • Blue Pharma
  • Actiza Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Aciclovir Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Aciclovir Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Aciclovir Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Aciclovir Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Aciclovir Drug Market Dynamics
  1. 2.1 Aciclovir Drug Industry Trends
  2. 2.2 Aciclovir Drug Industry Drivers
  3. 2.3 Aciclovir Drug Industry Opportunities and Challenges
  4. 2.4 Aciclovir Drug Industry Restraints
3 Aciclovir Drug Market by Manufacturers
  1. 3.1 Global Aciclovir Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Aciclovir Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Aciclovir Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Aciclovir Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Aciclovir Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Aciclovir Drug Manufacturers, Product Type & Application
  7. 3.7 Global Aciclovir Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Aciclovir Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Aciclovir Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Aciclovir Drug Tier 1, Tier 2, and Tier 3
4 Aciclovir Drug Market by Type
  1. 4.1 Aciclovir Drug Type Introduction
  2. 4.1.1 Topical Ointment
  3. 4.1.2 Oral Tablet
  4. 4.1.3 Lntravenous Dosage Forms
  5. 4.2 Global Aciclovir Drug Sales by Type
  6. 4.2.1 Global Aciclovir Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Aciclovir Drug Sales by Type (2021-2032)
  8. 4.2.3 Global Aciclovir Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global Aciclovir Drug Revenue by Type
  10. 4.3.1 Global Aciclovir Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Aciclovir Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global Aciclovir Drug Revenue Market Share by Type (2021-2032)
5 Aciclovir Drug Market by Application
  1. 5.1 Aciclovir Drug Application Introduction
  2. 5.1.1 Shingles
  3. 5.1.2 Herpes Simplex Virus Infection
  4. 5.1.3 Chickenpox in Immunocompromised Persons
  5. 5.1.4 Others
  6. 5.2 Global Aciclovir Drug Sales by Application
  7. 5.2.1 Global Aciclovir Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Aciclovir Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Aciclovir Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Aciclovir Drug Revenue by Application
  11. 5.3.1 Global Aciclovir Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Aciclovir Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Aciclovir Drug Revenue Market Share by Application (2021-2032)
6 Global Aciclovir Drug Sales by Region
  1. 6.1 Global Aciclovir Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Aciclovir Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Aciclovir Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Aciclovir Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Aciclovir Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Aciclovir Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Aciclovir Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Aciclovir Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Aciclovir Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Aciclovir Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Aciclovir Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Aciclovir Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Aciclovir Drug Revenue by Region
  1. 7.1 Global Aciclovir Drug Revenue by Region
  2. 7.1.1 Global Aciclovir Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Aciclovir Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Aciclovir Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Aciclovir Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Aciclovir Drug Revenue (2021-2032)
  8. 7.2.2 North America Aciclovir Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Aciclovir Drug Revenue (2021-2032)
  11. 7.3.2 Europe Aciclovir Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Aciclovir Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Aciclovir Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Aciclovir Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Aciclovir Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yiling Pharmaceutical
  2. 8.1.1 Yiling Pharmaceutical Company Information
  3. 8.1.2 Yiling Pharmaceutical Business Overview
  4. 8.1.3 Yiling Pharmaceutical Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yiling Pharmaceutical Aciclovir Drug Product Portfolio
  6. 8.1.5 Yiling Pharmaceutical Recent Developments
  7. 8.2 SHANGHAI CP GENERAL PHARMACEUTICAL
  8. 8.2.1 SHANGHAI CP GENERAL PHARMACEUTICAL Company Information
  9. 8.2.2 SHANGHAI CP GENERAL PHARMACEUTICAL Business Overview
  10. 8.2.3 SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Product Portfolio
  12. 8.2.5 SHANGHAI CP GENERAL PHARMACEUTICAL Recent Developments
  13. 8.3 UNITED LABORATOR IES
  14. 8.3.1 UNITED LABORATOR IES Company Information
  15. 8.3.2 UNITED LABORATOR IES Business Overview
  16. 8.3.3 UNITED LABORATOR IES Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 UNITED LABORATOR IES Aciclovir Drug Product Portfolio
  18. 8.3.5 UNITED LABORATOR IES Recent Developments
  19. 8.4 Kangzheng Pharmaceutical
  20. 8.4.1 Kangzheng Pharmaceutical Company Information
  21. 8.4.2 Kangzheng Pharmaceutical Business Overview
  22. 8.4.3 Kangzheng Pharmaceutical Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kangzheng Pharmaceutical Aciclovir Drug Product Portfolio
  24. 8.4.5 Kangzheng Pharmaceutical Recent Developments
  25. 8.5 Fresenius Kabi
  26. 8.5.1 Fresenius Kabi Company Information
  27. 8.5.2 Fresenius Kabi Business Overview
  28. 8.5.3 Fresenius Kabi Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fresenius Kabi Aciclovir Drug Product Portfolio
  30. 8.5.5 Fresenius Kabi Recent Developments
  31. 8.6 Zydus Pharmaceuticals
  32. 8.6.1 Zydus Pharmaceuticals Company Information
  33. 8.6.2 Zydus Pharmaceuticals Business Overview
  34. 8.6.3 Zydus Pharmaceuticals Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zydus Pharmaceuticals Aciclovir Drug Product Portfolio
  36. 8.6.5 Zydus Pharmaceuticals Recent Developments
  37. 8.7 Vectans Pharma
  38. 8.7.1 Vectans Pharma Company Information
  39. 8.7.2 Vectans Pharma Business Overview
  40. 8.7.3 Vectans Pharma Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Vectans Pharma Aciclovir Drug Product Portfolio
  42. 8.7.5 Vectans Pharma Recent Developments
  43. 8.8 Talent Healthcare
  44. 8.8.1 Talent Healthcare Company Information
  45. 8.8.2 Talent Healthcare Business Overview
  46. 8.8.3 Talent Healthcare Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Talent Healthcare Aciclovir Drug Product Portfolio
  48. 8.8.5 Talent Healthcare Recent Developments
  49. 8.9 RelonChem
  50. 8.9.1 RelonChem Company Information
  51. 8.9.2 RelonChem Business Overview
  52. 8.9.3 RelonChem Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 RelonChem Aciclovir Drug Product Portfolio
  54. 8.9.5 RelonChem Recent Developments
  55. 8.10 Novus Life Sciences
  56. 8.10.1 Novus Life Sciences Company Information
  57. 8.10.2 Novus Life Sciences Business Overview
  58. 8.10.3 Novus Life Sciences Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novus Life Sciences Aciclovir Drug Product Portfolio
  60. 8.10.5 Novus Life Sciences Recent Developments
  61. 8.11 Cipla
  62. 8.11.1 Cipla Company Information
  63. 8.11.2 Cipla Business Overview
  64. 8.11.3 Cipla Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cipla Aciclovir Drug Product Portfolio
  66. 8.11.5 Cipla Recent Developments
  67. 8.12 Blue Pharma
  68. 8.12.1 Blue Pharma Company Information
  69. 8.12.2 Blue Pharma Business Overview
  70. 8.12.3 Blue Pharma Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Blue Pharma Aciclovir Drug Product Portfolio
  72. 8.12.5 Blue Pharma Recent Developments
  73. 8.13 Actiza Pharma
  74. 8.13.1 Actiza Pharma Company Information
  75. 8.13.2 Actiza Pharma Business Overview
  76. 8.13.3 Actiza Pharma Aciclovir Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Actiza Pharma Aciclovir Drug Product Portfolio
  78. 8.13.5 Actiza Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Aciclovir Drug Value Chain Analysis
  2. 9.1.1 Aciclovir Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Aciclovir Drug Production Mode & Process
  6. 9.2 Aciclovir Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Aciclovir Drug Distributors
  9. 9.2.3 Aciclovir Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst